Lu-Ann Murdoch
ARTICLES BY THIS AUTHOR
- 4/28/2023
POP QUIZ: Ryaltris for allergic rhinitis
Do you know your stuff when it comes to this new intranasal spray? - 4/25/2023
U.S. FDA authorizes changes to simplify COVID-19 vaccine use in the United States
Bivalent Pfizer and Moderna vaccines are now authorized for all doses, while Pfizer and Moderna monovalent vaccines are no longer authorized for use. - 4/24/2023
New Omicron XBB.1.16 variant reaches second place on U.S. COVID-19 list
Nicknamed "Arcturus," this strain does not appear to be more dangerous than current strains, but may cause conjunctivitis symptoms in children. - 4/19/2023
More than Lyme disease: Be aware of increased risk of tick-borne diseases with climate change
In addition to Lyme disease, four other tick-borne diseases have started to emerge in Canada—anaplasmosis, babesiosis, Powassan virus and Borrelia miyamotoi disease. - 4/17/2023
Statins do not worsen muscle pain or injury after moderate-intensity exercise
Study compares the impact of prolonged walking on muscle injury in symptomatic and asymptomatic chronic statin users and control subjects. - 4/16/2023
POP QUIZ: Cannabis for chronic pain
New practice recommendations are here to help clinicians and patients with appropriate use of cannabinoid-based medicines. How closely did you read them? - 4/13/2023
Drug news—March/April 2023
A review of new launches, new indications, new dosage forms and Health Canada advisories. - 4/12/2023
New HIV testing guidelines now available for Ontario healthcare providers
Guidelines are designed to diagnose HIV early and identify people at high risk of acquiring HIV to enable referral for treatment and preventive services. - 4/10/2023
Ryaltris will soon be available for treating seasonal allergic rhinitis symptoms
Intranasal spray contains an antihistamine and a corticosteroid for twice-daily use in persons six years of age or older. - 4/4/2023
Canadian clinical practice recommendations for cannabis use for chronic pain
Guidelines are designed to promote appropriate use of cannabinoid-based medicines for the management of chronic pain and concurrent conditions.
